Osei-Wusu Stephen, Otchere Isaac Darko, Asare Prince, Ntoumi Francine, Zumla Alimuddin, Asante-Poku Adwoa, Yeboah-Manu Dorothy
Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo; Faculty of Sciences and Technology, University Marien Ngouabi, Brazzaville, Republic of Congo; University of Tübingen, Tübingen, Germany.
Int J Infect Dis. 2022 Nov;124 Suppl 1:S47-S49. doi: 10.1016/j.ijid.2022.03.016. Epub 2022 Mar 20.
The diversity in the lineages of Mycobacterium tuberculosis complex (MTBC) was initially considered insignificant. However, comparative genomics analysis of MTBC have found genomic variation among the genotypes with potential phenotypic implications.
Therefore, this viewpoint seeks to discuss the impact of the identified genotypic diversity on the physiology of MTBC and the potential implications on TB control.
Studies conducted in West Africa and other parts of Africa have unravelled the implications of the genomic diversity on phenotypes such as disease outcome, transmission dynamics and host immune response. The understanding of the phenotypic diversity among the different lineages of MTBC may be an important key to the fight against TB.
The relevance of these differences has been observed in the design of new control tools such as diagnostics and anti-TB drugs/vaccines. This only points to the fact that the diversity in MTBC cannot be ignored in future studies especially clinical trials for new vaccines and new anti-TB drugs.
结核分枝杆菌复合群(MTBC)谱系的多样性最初被认为并不重要。然而,对MTBC的比较基因组学分析发现,不同基因型之间存在基因组变异,可能具有表型影响。
因此,本观点旨在探讨已确定的基因型多样性对MTBC生理学的影响以及对结核病控制的潜在意义。
在西非和非洲其他地区进行的研究揭示了基因组多样性对疾病结局、传播动态和宿主免疫反应等表型的影响。了解MTBC不同谱系之间的表型多样性可能是抗击结核病的重要关键。
在诊断和抗结核药物/疫苗等新控制工具的设计中已观察到这些差异的相关性。这仅表明在未来的研究中,尤其是新疫苗和新抗结核药物的临床试验中,不能忽视MTBC的多样性。